whereas the iron delivered from normal reticuloendothelial stores or orally administered iron is sufficient for a marrow production response of only two to three times normal , the increased iron supply from nonviable red cells , hemolysis , or iron dextran infusions permits marrow production to rise acutely to levels of four to eight times normal .
C0302583
iron
C0022092
iron dextran